Cepheid is Danaher\'s internationally renowned company focusing on molecular diagnostic system technology. Its GeneXpert system integrates three steps of sample preparation, amplification and detection into an independent kit, and automates it, greatly reducing labor and pollution. At present, the incidence of cancer diseases remains high. The client intends to introduce product of \"tumor companion diagnosis and disease monitoring\", which has been well applied abroad, into Chinese market, hoping to judge market opportunity through market research.

1. What is estimated market size? 2. Who are competitors? 3. who are customers? 4. Figure out how to price?

interview with doctors in tumor departments and research on competing products, obtain following contents: 1. Incidence, patient characteristics and trends of various tumor diseases; 2. Tumor diagnosis process and treatment process, including applied testing methods and quantitative indicators; 3. Pain points in clinical diagnosis and disease monitoring of cancer; 4. Terminal fee of tumor testing; 5. Competition situation of tumor testing market.

1. Test process, characteristics, test cost and demand characteristics of molecular cancer test in China; 2. Tumor molecular detection market size in China: including the overall market size, various molecular detection market size segmentation and future market development potential; 3. Competition pattern of China\'s cancer molecular detection market, advantages and disadvantages of each enterprise, product characteristics and price; Key enterprise information: product, price, sales strategy, sales model, etc. 5. Suggestions on entering the Chinese market.